The relationship between HbA1c and the activities of daily living in complex chronic patients with and without intracerebral hemorrhage

TL;DR

Higher HbA1c levels are linked to better daily living abilities in complex chronic patients without intracerebral hemorrhage, but not in those with it.

Contribution

First observation that elevated HbA1c is associated with improved ADL in CCPs without ICH, contradicting traditional views of HbA1c as harmful.

Findings

Elevated HbA1c is positively associated with Barthel scores in non-ICH patients.

HbA1c shows no significant association with ADL in patients with ICH.

Findings contradict traditional understanding of HbA1c's adverse effects.

Abstract

Associations between HbA1c and adverse outcomes in ischemic and hemorrhagic stroke have been confirmed. It is still unclear whether HbA1c is related to the activities of daily living (ADL) score in complex chronic patients (CCP) with and without intracerebral hemorrhage (ICH).

The associations between HbA1c and ADL (Barthel score) in CCP with ICH and without ICH were evaluated, respectively.

We have analyzed data from a previous cohort study involving in 3594 CCPs without a ICH history at baseline, who were followed up for 5 years to assess ICH episode.

One hundred sixty-one ICH case were detected in a total of 3594 patients during the period of follow up for 5 years. Our nonlinear analysis suggested positive trends on the association between HBA1c and Barthel score in ICH and non-ICH patients, respectively. The multivariate linear regression analysis showed that elevated HbA1c was positively associated with a higher Barthel score among all study population (β = 1.25, 95% CI: 0.92, 1.59; P < 0.0001) with adjusted age and sex. Among non-ICH patients, increased HbA1c was still positively associated with an increased Barthel score (β = 1.24, 95% CI: 0.90, 1.58; P < 0.001). However, HbA1c appeared to have no any relationship with Barthel score in ICH patients (β = 1.87, 95% CI: -0.07, 3.82; P = 0.0613) after adjustment for age and sex. By additionally using sensitivity analysis, we still observed that the strong relationship was still existed in non-ICH patients (β = 0.90, 95% CI: 0.56, 1.24; P < 0.001) but not in ICH patients (β = 1.88, 95% CI: -0.10, 3.86; P = 0.0649).

We observed for the first time that elevated HbA1c is associated with better ADL in CCPs without ICH but not in those with ICH. This interesting discovery contradicts the traditional adverse effects of elevated HbA1c.

Figures